Potential 100 bagger Biotech missed by the market, page-987

Very simple really,we are about to start trials for glaucoma using our drug EMTINB
1.Every drug company in the world will be watching this very closely
2.Glaucoma is a 4 billion dollar a year industry
3.Alzheimers and dementia is a 6 billion dollar a year industry
4,Multiple sclerosis is a 4 billion a year industry
5.Just one direct sign of a positive outcome will have every drug company in the world trying to get EMTINB
6.One company will want full control of the drug going to any company treating any of these diseases
7.EMTINB is different to any drug in the market place

500 million market cap will look like a joke if this pans,this could be a 20 billion dollar drug